Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Type-specific testing for herpes simplex virus.

Lara Strick1, Anna Wald

  • 1Seattle HIV Prevention Trials Unit, 901 Boren Ave., Suite 1300, Seattle, WA 98104, USA. strick@u.washington.edu

Expert Review of Molecular Diagnostics
|July 1, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mathematical modeling of the population-level impact of hypothetical herpes simplex virus type 2 curative therapy.

Communications medicine·2026
Same author

The safety, reactogenicity, and immunogenicity of the self-amplifying mRNA COVID-19 vaccine GRT-R910 as a booster in healthy adults.

Vaccine·2026
Same author

Nonavalent HPV vaccine to prevent recurrent anal or vulvar high-grade squamous intraepithelial lesions (VIVA trial): A randomized, double-blind, placebo-controlled trial.

International journal of cancer·2026
Same author

Herpes Simplex Virus Type 2 Screening in Persons with and Without HIV: Evidence, Challenges, and Future Directions.

Current HIV/AIDS reports·2026
Same author

Herpes Simplex Virus Type 1 and Type 2 Western Blot Serology Test Results From 1999 to 2020 in a US Reference Laboratory.

Sexually transmitted diseases·2025
Same author

Limitations of acyclovir and identification of potent HSV antivirals using 3D bioprinted human skin equivalents.

Nature communications·2025
Same journal

Bacterial respiratory infections: advances in diagnostic strategies.

Expert review of molecular diagnostics·2026
Same journal

Artificial intelligence in molecular diagnostics for pandemic preparedness.

Expert review of molecular diagnostics·2026
Same journal

Navigating PD-L1 testing in immuno-oncology: analytical robustness, clinical validation, and the role of the VENTANA SP263 assay.

Expert review of molecular diagnostics·2026
Same journal

Extracellular vesicles as diagnostic and prognostic biomarkers in non-small cell lung cancer.

Expert review of molecular diagnostics·2026
Same journal

Explainable epigenetic aging clocks: an overview of existing AI models and approaches.

Expert review of molecular diagnostics·2026
Same journal

Neuro-axonal injury biomarker serum neurofilament light chain is associated with osteoarthritis: a dual-cohort study from NHANES and UK Biobank.

Expert review of molecular diagnostics·2026
See all related articles

Genital herpes is rising globally. Accurate diagnosis requires type-specific antibody tests for herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), particularly those using glycoprotein G, to guide treatment and counseling.

Area of Science:

  • Infectious Diseases
  • Virology
  • Immunology

Background:

  • Genital herpes prevalence is increasing worldwide.
  • Accurate diagnostic tools are crucial for managing herpes simplex virus (HSV) infections.
  • Distinguishing between HSV-1 and HSV-2 is important for prognosis and patient counseling.

Purpose of the Study:

  • To highlight the importance of type-specific antibody tests for diagnosing genital herpes.
  • To emphasize the accuracy of glycoprotein G-based tests for HSV-1 and HSV-2.
  • To identify appropriate populations for serologic testing.

Main Methods:

  • Review of available type-specific antibody tests for HSV-1 and HSV-2.
  • Evaluation of test accuracy, focusing on glycoprotein G-based assays.

Related Experiment Videos

  • Identification of patient groups benefiting from serologic testing.

    • Main Results:

    • Only glycoprotein G-based type-specific antibody tests offer acceptable accuracy for HSV-1 and HSV-2.
    • Accurate differentiation between HSV-1 and HSV-2 is essential for clinical management.
    • Specific populations, including those with uncertain diagnoses, high-risk individuals, partners of infected persons, HIV-infected individuals, and pregnant women, are suitable candidates for testing.

    Conclusions:

    • Type-specific serologic testing is vital for accurate genital herpes diagnosis.
    • Glycoprotein G-based tests are recommended for reliable HSV type differentiation.
    • Targeted testing ensures appropriate patient care and counseling for genital herpes.